Paracetamol Accord (Paracetamol)

Paracetamol acts by inhibiting cyclooxygenase enzymes in the central nervous system, which lowers prostaglandin production. This reduction diminishes pain signaling and resets the hypothalamic temperature set‑point, providing both analgesic and antipyretic effects.

The dosage of Paracetamol Accord is determined by the prescribing clinician based on the patient’s age, weight, clinical condition, and renal or hepatic function. No fixed regimen is provided here; the prescriber sets the appropriate dose.

Paracetamol is generally considered compatible with pregnancy and lactation when used at recommended doses, but safety information for the intravenous formulation is limited. Clinicians should evaluate the risk‑benefit ratio for each patient and follow local guidelines.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifying trade or institutional credentials before providing pricing, availability, shipping details (including cold‑chain where needed), and import documentation.

Compared with non‑steroidal anti‑inflammatory drugs (NSAIDs), paracetamol provides analgesia and antipyresis without significant anti‑inflammatory activity or gastrointestinal irritation. Unlike opioids, it carries no risk of respiratory depression or dependence, making it a preferred option for mild to moderate pain when rapid effect is desired.

Paracetamol Accord should be stored at 2‑8 °C, protected from light, and must not be frozen or shaken. Keep the solution in its original packaging until use, and discard any product that appears discolored or contains particles.

Paracetamol Accord is given by intravenous infusion under the supervision of qualified medical staff. The infusion rate and volume are set by the prescriber, and the solution should be administered using aseptic technique to avoid contamination.

The most serious risks include severe allergic reactions such as anaphylaxis, rare skin conditions like Stevens‑Johnson syndrome, and hepatotoxicity, especially in cases of overdose or pre‑existing liver disease. Prompt medical attention is required if any of these symptoms arise.

Paracetamol Accord should be avoided in patients with known hypersensitivity to paracetamol or any excipients in the formulation, in those with severe hepatic impairment, and in individuals who have experienced serious adverse reactions to paracetamol in the past.